Comparative efficacy and safety of immune checkpoint inhibitors combined with antiangiogenic agents for unresectable hepatocellular carcinoma in patients with Child-Pugh A versus B cirrhosis: a single-center, retrospective study.
Saved in:
| Title: | Comparative efficacy and safety of immune checkpoint inhibitors combined with antiangiogenic agents for unresectable hepatocellular carcinoma in patients with Child-Pugh A versus B cirrhosis: a single-center, retrospective study. |
|---|---|
| Authors: | Liu, Dan1 (AUTHOR), Yang, Zirong2 (AUTHOR), Wang, Lilin1 (AUTHOR), Ma, Lina1 (AUTHOR), Hou, Wei1 (AUTHOR), Ren, Shan1 (AUTHOR), Zheng, Sujun1 (AUTHOR) zhengsujun@ccmu.edu.cn, Lu, Junfeng3 (AUTHOR) junfengdoc@ccmu.edu.cn |
| Source: | BMC Cancer. 10/27/2025, Vol. 25 Issue 1, p1-9. 9p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
